Badiou S, Vuillot O, Bargnoux A S, Kuster N, Lefebvre S, Sebbane M, Cristol J P, Dupuy A M
Department of Biochemistry, Lapeyronie University Hospital, Montpellier, France.
PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
Pract Lab Med. 2019 Jun 12;16:e00128. doi: 10.1016/j.plabm.2019.e00128. eCollection 2019 Aug.
Centrifugation is a consuming time step which participates to increase the turnaround time (TAT) in laboratories, likewise hemolysis sample that needs a re-sampling could delay management of patients. Recently, it has been postulated that BD Barricor™ tube could allow to decrease the centrifugation time and prevent hemolysis, two key feature to ensure high-quality results.Aim of the study was to evaluate the impact of replacing 4 mL BD vacutainer heparin lithium tube by low vacuum 3.5 mL BD vacutainer Barricor™ tube in an emergency department (ED) on hemolysis rate and TAT.
Data of hemolysis index (HI) and TAT were compared between the first period of 15 days using 4 mL BD vacutainer heparin lithium tubes with 15 min at 2000xg as centrifugation setting and a second period of 15 days using BD vacutainer Barricor™ tube centrifuged 3 min at 4000xg.
A significantly reduced time duration between reception of sample and available results in informatics lab system was observed with the reduction time of centrifugation allowed by use of Barricor™ tube compared to regular heparin lithium tubes (p < 0.001). A significative decrease in hemolysis rate also occurred in the second period as samples with HI < 10 reached from 52.5% in the first period to 68.5% (p < 0.001) in the second.
Low vacuum Barricor tubes allowing a higher speed of centrifugation improve lab TAT without impairment of sample quality as a significant reduction of hemolysis was observed, a double advantage which is of particular interest for ED.
离心是一个耗时步骤,会增加实验室的周转时间(TAT),同样,需要重新采样的溶血样本可能会延迟患者的治疗。最近,有人推测BD Barricor™管可以减少离心时间并防止溶血,这是确保高质量结果的两个关键特性。本研究的目的是评估在急诊科(ED)用低真空3.5 mL BD真空采血管Barricor™管取代4 mL BD真空采血管肝素锂管对溶血率和TAT的影响。
比较了两个阶段的数据,第一阶段为15天,使用4 mL BD真空采血管肝素锂管,以2000xg离心15分钟;第二阶段为15天,使用BD真空采血管Barricor™管,以4000xg离心3分钟。
与常规肝素锂管相比,使用Barricor™管允许的离心时间减少,从而使信息实验室系统中样本接收与可获得结果之间的持续时间显著缩短(p < 0.001)。在第二阶段,溶血率也显著降低,因为HI < 10的样本从第一阶段的52.5%上升到第二阶段的68.5%(p < 0.001)。
低真空Barricor管允许更高的离心速度,可改善实验室TAT,且不会损害样本质量,因为观察到溶血显著减少,这一双重优势对急诊科尤为重要。